Prognostic Value of CD9 in Solid Tumor: A Systematic Review and Meta-Analysis
Numerous clinical studies investigated how low expression of CD9 predicts poor prognosis of solid tumor. However, the results were inconclusive. This present meta-analysis was therefore performed to determine the prognostic value of CD9 expression in solid tumors. In this meta-analysis, 25 studies i...
Guardado en:
Autores principales: | Ping Zeng, Meng Si, Rui-xia Sun, Xu Cheng, Xiao-yang Li, Min-bin Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/17d46abba540471eac339dd3aedc15de |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PROGNOSTIC VALUE OF TUMOR NECROSIS FACTOR-ALPHA IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
por: E. N. Zotina, et al.
Publicado: (2016) -
Progression-free survival/time to progression as a potential surrogate for overall survival in HR+, HER2– metastatic breast cancer
por: Forsythe A, et al.
Publicado: (2018) -
Sarcopenia’s Prognostic Impact on Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
por: Donggun Lee, et al.
Publicado: (2021) -
Clear Cell Carcinoma of the Endometrium: Evaluation of Prognostic Parameters in 27 Cases
por: Zhiyang Zhang, et al.
Publicado: (2021) -
Prognostic impact of microsatellite instability in gastric cancer
por: Cesar Zepeda-Najar, et al.
Publicado: (2021)